North America Apheresis Market Worth will reach USD 0.94 billion by 2021
The North America Apheresis Market expected to reach USD 0.94 billion by 2021 and estimated to be growing at a CAGR of 10.87%, Says Market Data Forecast.
(EMAILWIRE.COM, November 03, 2017 ) The North America Apheresis Market was worth USD 0.56 billion in 2016 and estimated to be growing at a CAGR of 10.87%, to reach USD 0.94 billion by 2021. Apheresis is a procedure of blood component separation using centrifugation or membrane filtration technology. This procedure is performed either for donation of a blood component or for treatment of a disease by removal of the diseased or disease-causing blood component. Whole blood is extracted from donor or patient’s body, processed through apheresis machine, and the desired blood components are separated based on their molecular weight, size, and affinity for particular substance.
Browse report details @ http://www.marketdataforecast.com/market-reports/north-america-apheresis-market-3090/
The U.S Government has been very supportive in the funding of R&D of Apheresis through its benefit programs such as Medicaid, Medicare, veterans’ health administration military and employee insurance programs. Medicare provides coverage for apheresis regardless of whether the procedure is performed in a hospital or a blood centre. In addition, private insurers have recently begun to closely examine apheresis procedures and issue policy statements pertaining to coverage.
Market Conditions:
The rising incidence of chronic lifestyle diseases such as diabetes, kidney disorders, & respiratory diseases, increasing demand for blood components and favourable reimbursement policies for apheresis treatment are driving the equipment market share. However, the growth of the market is restrained by the scarcity of qualified donors, lack of awareness about
apheresis and the high cost of these procedures.
North America Apheresis Market Segmentation:
• By Product: Introduction, Apheresis devices (Plasma separators, Plasma component separators, Immunoadsorption Columns, Plasma Perfusion Columns and Hemoperfusion Columns) and Apheresis disposables
• By Procedure: Introduction, Donor Apheresis and Therapeutic Apheresis
• By Application: Introduction, Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases and Cardiovascular Diseases
• By Technology: Centrifugation (Intermittent Flow and Continuous Flow) and Membrane Separation
• By End-User: Introduction, Private Blood Collection Centres, Public Blood Collection Centres and Hospitals
• By Geography: Introduction, United States and Canada
North America has the largest market in 2016 due to its healthcare infrastructure and high demand for plasma for production of plasma derived medicines. Disposables products segment is expected to have largest share in North America apheresis market.
Current Key Players of this Market:
The key players in this market are Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Terumo BCT, Inc., Fresenius Medical Care, Kawasumi Laboratories Inc., Cerus Corporation, HemaCare Corporation, Kaneka Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd., Therakos, Inc., and Medica S.p.A.
Avail Free Sample Market Brochure of the report for more information, Get a Copy @ http://www.marketdataforecast.com/market-reports/north-america-apheresis-market-3090/request-sample
About MarketDataForecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Media Contact:
Abhishek Shukla
International Business Development Manager
Market Data Forecast
Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Browse report details @ http://www.marketdataforecast.com/market-reports/north-america-apheresis-market-3090/
The U.S Government has been very supportive in the funding of R&D of Apheresis through its benefit programs such as Medicaid, Medicare, veterans’ health administration military and employee insurance programs. Medicare provides coverage for apheresis regardless of whether the procedure is performed in a hospital or a blood centre. In addition, private insurers have recently begun to closely examine apheresis procedures and issue policy statements pertaining to coverage.
Market Conditions:
The rising incidence of chronic lifestyle diseases such as diabetes, kidney disorders, & respiratory diseases, increasing demand for blood components and favourable reimbursement policies for apheresis treatment are driving the equipment market share. However, the growth of the market is restrained by the scarcity of qualified donors, lack of awareness about
apheresis and the high cost of these procedures.
North America Apheresis Market Segmentation:
• By Product: Introduction, Apheresis devices (Plasma separators, Plasma component separators, Immunoadsorption Columns, Plasma Perfusion Columns and Hemoperfusion Columns) and Apheresis disposables
• By Procedure: Introduction, Donor Apheresis and Therapeutic Apheresis
• By Application: Introduction, Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases and Cardiovascular Diseases
• By Technology: Centrifugation (Intermittent Flow and Continuous Flow) and Membrane Separation
• By End-User: Introduction, Private Blood Collection Centres, Public Blood Collection Centres and Hospitals
• By Geography: Introduction, United States and Canada
North America has the largest market in 2016 due to its healthcare infrastructure and high demand for plasma for production of plasma derived medicines. Disposables products segment is expected to have largest share in North America apheresis market.
Current Key Players of this Market:
The key players in this market are Asahi Kasei Medical Co., Ltd., Haemonetics Corporation, Terumo BCT, Inc., Fresenius Medical Care, Kawasumi Laboratories Inc., Cerus Corporation, HemaCare Corporation, Kaneka Corporation, B. Braun Melsungen AG, and Nikkiso Co., Ltd., Therakos, Inc., and Medica S.p.A.
Avail Free Sample Market Brochure of the report for more information, Get a Copy @ http://www.marketdataforecast.com/market-reports/north-america-apheresis-market-3090/request-sample
About MarketDataForecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Media Contact:
Abhishek Shukla
International Business Development Manager
Market Data Forecast
Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results